Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2025

Jun 4, 2025

34491_dirs_2025-06-04_d82751b8-9e5c-4857-9186-74e9a5b71f8f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2025-05-27

Reporting Person: Pire Shari Lisa (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-27 Common Stock M 9826 Acquired 14028 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-27 Restricted Stock Units $ M 9826 Disposed Common Stock (9826) Direct
2025-06-03 Restricted Stock Units $ A 21000 Acquired Common Stock (21000) Direct

Footnotes

F1: Represents the vesting of Restricted Stock Units ("RSUs") on May 27, 2025.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F4: The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.